Latest News
Salvepar has finalized the sale of its entire stake in Thermador Groupe.
Salvepar was a shareholder of Thermador Groupe since May 2008 and had begun to divest its stake in 2014.
The sale has seen Salver realise a gain of EUR7.2 million, among which EUR5.2 million will be recognised in 2015. The aggregate sale price corresponds to 1.8 time the amount initially invested.
QIC’s Global Infrastructure Fund (the fund) has secured initial capital commitments totalling USD528 million from four institutional investors.
CEO Damien Frawley, says: “We’re pleased that major institutional investors, including an Asian sovereign wealth fund and a major Australian pension scheme, have committed to our new global infrastructure fund. This is an exciting time for investment opportunities and further growth in the infrastructure sector in key markets around the world, including in the US and Europe. We believe QIC’s infrastructure pedigree is second to none, and we’re delighted to be able to make available to more institutional investors the successful global
Joe Bedford (pictured), corporate partner at law firm Stevens & Bolton who advised the management team of TGI UK on its recent acquisition by Electra Partners, looks at how the casual dining sector is attracting interest from private equity investors…
Looking at trends over recent months and years, together with current market rumours of further activity, it is clear that private equity has been showing significant interest in the casual dining sector. 2014 ended with the acquisition of TGI UK by Electra but that was only the latest in a long line of casual dining deals, including Hawksmoor (Graphite Capital);
Zetta Venture Partners, a venture capital firm focused on the high-growth analytics market, has closed its first fund at USD60 million.
Mark Gorenberg, a 25-year veteran venture capitalist, and Ash Fontana, who formerly launched online fundraising at AngelList, are Zetta’s managing directors.
Debuting with a portfolio of eight investments, Zetta is committed to delivering exceptional returns for investors and entrepreneurs alike. The firm has offices in San Francisco and Utah’s Silicon Slopes.
“Every decade, there’s the start of a cataclysmic shift in technology markets,” says Gorenberg. “Today that shift is to analytics – a fast growing market combining data and
GoldenTree Asset Management has appointed Dean Merritt as Partner, heading up European restructurings and turnarounds.
He is based in GoldenTree’s London office and will be working closely with Ted Lodge, Global Head of Restructurings and Turnarounds.
“We have worked with Dean for years and are very excited to be joining forces with him in Europe,” says Steve Tananbaum, GoldenTree’s Managing Partner and Chief Investment Officer. “Dean has a notable record of successful European restructurings, an area which is an important part of our distressed investment strategy; he’s highly regarded in Europe for his roles as financial and operational restructuring adviser,
Force Over Mass Capital has launched a Seed Enterprise Investment Scheme (SEIS) – Enterprise Investment Scheme (EIS) fund which will invest in fast growth technology companies.
The fund will provide high net-worth investors with the opportunity to invest in technology, through a risk-mitigated portfolio of early stage technology companies with high growth potential and potential tax reliefs of up to 64% of the capital.
The fund is closing the funding gap between crowd funding and traditional venture capitalists in the start-up technology sector allowing investors to benefit from its significant organic growth potential. The fund aims to raise GBP15
Duane Morris has appointed Ute Mueller (pictured) as a partner in the firm’s Corporate Practice Group in London.
Mueller's addition further strengthens Duane Morris' international corporate capabilities. She joins Duane Morris from Boodle Hatfield.
Mueller focuses her practice on domestic UK and international transaction work, with special attention to the Anglo-German market and the metal commodities sector. She represents businesses and entrepreneurs with domestic and cross-border mergers, acquisitions, MBOs, MBIs and joint ventures. Mueller guides her clients on a day-to-day basis on multiple commercial agreements, specifically in the hard commodities sector. She is qualified as an English solicitor, as
Beringea, manager of the ProVen Venture Capital Trusts, has sold the VCTs’ stakes in Speed Trap Holdings (STH), a digital data analytics company, to IS Solutions plc.
STH is the parent company of Celebrus Technologies – the developer of software that allows organisations to understand their customers’ interactions with their websites, mobile applications and social media channels in real time on an individual and personalised level.
Beringea first invested in the STH in 2010 through ProVen VCT and ProVen Growth and Income VCT. It is anticipated that the sale to IS Solutions will generate a circa 2x return on investment
Vector Capital (Vector) is to acquire Saba, a specialist in cloud-based intelligent management solutions, for USD9.00 per share in an all cash offer.
"Over the course of Saba's comprehensive review, the Board of Directors and our advisors evaluated a wide range of strategic alternatives, and engaged with a number of parties. We are pleased to have reached this agreement with Vector, which provides significant cash value for our shareholders. Our Board unanimously believes that this is the best outcome for Saba, our shareholders, customers, partners and employees," says Bill Russell, Saba's Non-Executive Chairman.
"Over the last 17 years, Saba has
Edmond de Rothschild Investment Partners’ BioDiscovery 3 portfolio company, GlycoVaxyn has been acquired by GlaxoSmithKline (GSK) in an all-cash transaction valuing the company at approximately USD212 million.
GlycoVaxyn, founded in 2004, is a spin out of the Swiss Polytechnic Institute of Zürich. It has developed a biological conjugation platform which enables the development of a new generation of conjugate vaccines against major bacterial infections. Vaccines this type are protecting children and adults against several infections among others pneumonia, meningitides, and the role of vaccination to prevent bacterial infections is becoming increasingly important with the development of resistance to antibiotic treatments.
Special Reports
Featured
- Insight
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
